CDKL2 and gastric cancer: Recently, a study by Fang et al. also performed in GC claimed that CDKL2 could impair cell growth and invasion and that patients with low CDKL2 expression had significantly poorer disease-free survival and OS compared with those with high CDKL2 expression [31].